Search Results
Nov 10, 2025, 16:28 ET Xtant Medical Reports Third Quarter 2025 Financial Results
on third-party manufacturers and suppliers; risks associated with its acquisitions and the integration of those businesses; anticipated shortages of stem cells which will adversely affect future revenues; the ability to implement successfully its future growth initiatives and risks associated therewith;
More news about: Xtant Medical Holdings, Inc.
Nov 10, 2025, 13:50 ET UrbanGeekz CEO Kunbi Tinuoye Joins Speaker Lineup at Africa Tech Festival 2025 in Cape Town
multimedia platform covers tech, startups, and business. Its mission is to make tech 'cool' and accessible while highlighting innovative careers and STEM-related fields as exciting and rewarding paths, especially for women and underrepresented groups. About
More news about: UrbanGeekz
Nov 10, 2025, 09:30 ET Visionary Holdings (Nasdaq: GV) Launches Stem Cell-Based Anti-Aging Product Line, Accelerating Expansion into Asia's Premium Regenerative Medicine Market
Limited, has official launch of its medical-grade stem cell anti-aging product line, initially targeting the Chinese mainland and broader Asian markets. This launch marks a major milestone following GV's entry into the stem cell and medical aesthetics sector earlier this year,
More news about: Visionary Holdings
Nov 10, 2025, 09:04 ET FDA Completes Safety for Gallant's First Ready-to-Use Stem Cell Therapy for Refractory FCGS
gingivostomatitis (FCGS). This milestone brings Gallant one step closer to delivering the potential first FDA-approved, ready-to-use stem cell therapy in veterinary medicine. SAN DIEGO,
More news about: Gallant
Nov 10, 2025, 08:00 ET Proxy Advisory Firms, ISS, Glass Lewis, and Egan-Jones, Conclude Change is Warranted at Cracker Barrel and Recommend Vote AGAINST Cracker Barrel Nominees
represented) remains fundamentally unclear…. As a result, the balance of Cracker Barrel investors cannot be certain whether the adopted provisions stem directly from a wide and deep engagement circuit or if the tail is wagging the dog here".
More news about: Biglari Capital Corp.
Nov 10, 2025, 06:36 ET DFRobot UNIHIKER K10 Crowned Winner in Teach Secondary's EdTech & Software Category at 2025 TeachCo Resource Awards
entries. The UNIHIKER K10 was selected by the judges for its outstanding contribution to advancing hands-on AI and STEM education. Designed specifically for K–12 STEM education and programming beginners, the UNIHIKER K10 is a palm-sized AI coding board that integrates vision AI,
More news about: DFRobot
Nov 10, 2025, 00:01 ET 25th anniversary edition of Lise Bourbeau's bestseller Les 5 blessures qui empêchent d'être soi-même sold over 3 million copies
Portuguese, Romanian, Russian, Czech, Turkish, Vietnamese... This book shows how all physical, emotional and mental problems stem from five major wounds: rejection, abandonment, humiliation, betrayal and injustice. The very detailed description of these wounds, and of the masks
More news about: Les Éditions E.T.C.
Nov 08, 2025, 13:30 ET 2026 Toy of the Year Award Finalists Unveiled at Chicago Toy & Game Fair
and games specifically designed to meet an educational purpose, such as building a specific skill or teaching a particular subject area, including STEM, literacy, or social-emotional learning. 3Doodler Start+ Essentials 3D
More news about: The Toy Foundation
Nov 08, 2025, 10:00 ET Vaughn College Hosts 11th Annual Manufacturing Day to Promote Career Opportunities and to Inspire the Next Generation of Engineering and Technology Professionals
The annual event hosted by Vaughn's Engineering and Technology Department featuredpresentations from industry experts and STEM workshops for local community colleges and highschool students. FLUSHING,
More news about: Vaughn College of Aeronautics and Technology
Nov 07, 2025, 17:00 ET Lunai Bioworks schafft es, sowohl primäre als auch metastasierte Bauchspeicheldrüsentumoren in präklinischen humanisierten Modellen komplett zurückzubilden, was einen Durchbruch in der allogenen Krebsimmuntherapie bedeutet
der zellbasierten Immuntherapien der nächsten Generation." Der vollständige Artikel mit dem Titel „Modified Hematopoietic Stem Cell-Derived Dendritic Cell Therapy Retained Tumor-Inhibitory Function and Led to Regression of Primary and Metastatic Pancreatic Tumors in Humanized
More news about: Lunai Bioworks Inc.
Nov 07, 2025, 16:49 ET Lunai Bioworks、前臨床のヒト化モデルにおいて、原発および転移性膵臓がんの完全退縮を達成──オールロジェニックがん免疫療法における画期的なブレークスルーを示す
Weinstein氏は述べた。「これは、研究段階のイノベーションから臨床応用への移行における重要な転換点を示しており、Lunai を次世代細胞免疫療法の最前線に位置づけるものです。」 全文記事「Modified Hematopoietic Stem Cell-Derived Dendritic Cell Therapy Retained Tumor-Inhibitory Function and Led to Regression of Primary and Metastatic Pancreatic Tumors in Humanized
More news about: Lunai Bioworks Inc.
Nov 07, 2025, 02:00 ET Lunai Bioworks réussit à éliminer complètement les tumeurs pancréatiques primaires et secondaires dans des modèles humanisés précliniques, marquant une avancée significative pour l'immunothérapie allogénique contre le cancer
l'avant-garde des immunothérapies cellulaires de nouvelle génération. » L'article complet, intitulé « Modified Hematopoietic Stem Cell-Derived Dendritic Cell Therapy Retained Tumor-Inhibitory Function and Led to Regression of Primary and Metastatic Pancreatic Tumors in Humanized
More news about: Lunai Bioworks Inc.
Nov 07, 2025, 02:00 ET Lunai Bioworks logra la regresión completa de tumores pancreáticos primarios y metastásicos
la vanguardia de las inmunoterapias celulares de próxima generación". El artículo completo titulado "Modified Hematopoietic Stem Cell-Derived Dendritic Cell Therapy Retained Tumor-Inhibitory Function and Led to Regression of Primary and Metastatic Pancreatic Tumors in Humanized
More news about: Lunai Bioworks Inc.
Nov 06, 2025, 18:52 ET Lunai Bioworks 在臨床前人源化模型內，實現原發性和轉移性胰臟腫瘤的完全消退，標誌為同種異體癌症免疫療法的突破
表示：「這些研究結果顯示我們的載體最佳化策略保持治療效力，同時提升我們的同種異體 DC 平台達到 IND 申報研究的門檻。這標誌我們從研究創新走向臨床轉化，並邁入重要轉捩點——定位 Lunai 為新一代細胞免疫療法的最重要地位。」 全文標題為「Modified Hematopoietic Stem Cell-Derived Dendritic Cell Therapy Retained Tumor-Inhibitory Function and Led to Regression of Primary and Metastatic Pancreatic Tumors in Humanized
More news about: Lunai Bioworks Inc.
Nov 06, 2025, 17:07 ET DARZALEX FASPRO® is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma
consolidation in newly diagnosed patients who are eligible for autologous stem cell transplant In combination with bortezomib, melphalan, and prednisone in newly diagnosed patients who are ineligible for autologous stem cell transplant In combination with lenalidomide
More news about: Johnson & Johnson
Nov 06, 2025, 11:43 ET Partsol Defense Secures U.S. Department of War Contract for Checkmate: The AI Stem Cell-Powered Platform Protecting America's Critical Supply Chains
global vendor networks. Built on AI Stem Cell technology, Checkmate is uniquely designed to identify, trace, and neutralize supply chain vulnerabilities that could threaten national security. Checkmate: Powered by AI Stem Cells for Adaptive, Forensic IntelligenceAt
More news about: Partsol
Nov 06, 2025, 11:18 ET 10,000 Acts of Kindness Lead to $1 Million Gift to Fight Hunger
special education programs for those with disabilities, disaster relief, drug and alcohol rehabilitation, environmental conservation, and the promotion of STEM education. To learn more about Kimley-Horn's involvement in the community and The Kimley-Horn Foundation, visit
More news about: Kimley-Horn
Nov 06, 2025, 10:58 ET Top U.S. Stem-Cell Provider Named as Celebrity Demand Soars
Innovations Stem Cell Center offers safe, standardized, and affordable regenerative therapy as celebrities seek unregulated procedures abroad. Innovations Stem Cell Center, recently named the top U.S. stem-cell therapy provider by Life Sciences Review, offers
More news about: iMedstem LLC DBA Innovations Stem Cell Center
Nov 06, 2025, 10:00 ET LivePerson Launches Conversation Simulator to De-risk Generative AI and Accelerate AI Adoption
As global brands rush to integrate GenAI into customer experiences, many face mounting challenges that stem from GenAI's unpredictability. LivePerson's new platform, Conversation Simulator, directly addresses the issue. "With Conversation
More news about: LivePerson, Inc.
Nov 06, 2025, 08:00 ET FeatherSnap Uses AI to Inspire Nature Lovers this National STEM Day
"National STEM Day reminds us that science is all around us, and that learning doesn't only happen in classrooms," said Maria Kincaid, Ornithology Research Specialist at FeatherSnap. "FeatherSnap bridges technology and the natural world, helping students and families experience STEM concepts like
More news about: FeatherSnap
Nov 06, 2025, 08:00 ET Servier's New and Updated Data at 2025 ASH Annual Meeting Highlight Commitment to Hematology Research
69.1 The five-year survival rate is approximately 31.9%.1 For 6 to 10 percent of AML patients, the mutated IDH1 enzyme blocks normal blood stem cell differentiation, contributing to the genesis of acute leukemia.3 TIBSOVO IMPORTANT SAFETY
More news about: Servier Pharmaceuticals
Nov 06, 2025, 07:29 ET ELEGOO présentera à Formnext 2025 ses dernières réalisations pour créer son propre écosystème d'impression 3D
fabrication intelligente, spécialisée dans la R&D, ainsi que dans la fabrication et la vente d'imprimantes 3D grand public, de graveurs laser, de kits STEM et d'autres produits technologiques intelligents. Située à Shenzhen, la Silicon Valley de la Chine, l'entreprise a vendu à ce jour des millions de produits
More news about: Elegoo
Nov 06, 2025, 07:24 ET ELEGOO presentará en Formnext 2025 sus últimos logros en la creación de su propio ecosistema de impresión 3D
crecimiento en la industria global de la fabricación inteligente, especializada en I+D, fabricación y venta de impresoras 3D, grabadoras láser, kits STEM y otros productos de tecnología inteligente para el consumidor. Con sede en Shenzhen, el Silicon Valley de China, la empresa ha vendido millones de
More news about: Elegoo
Nov 06, 2025, 07:00 ET NewcelX Announces Scientific Leadership with the Head of Division of Medical Neurosciences at the Department of Neurology at Hadassah, Prof. Tamir Ben-Hur on Its Scientific Advisory Board
Neurology at Hadassah University Medical Center and the Hebrew University of Jerusalem, is widely recognized as a global expert in neuroimmunology and stem-cell-based regenerative medicine. Prof. Tamir Ben-Hur said, "It is an honor to join this scientific
More news about: NewcelX Ltd.
Nov 06, 2025, 04:54 ET Epidemic Sound expands Adapt functionality to give creators and brands more creative control
advanced features, offering creators unprecedented control over music customization for their content The update introduces stem-level control enabling creators to edit specific musical stems, add missing ones, and easily switch between granular adaptations
More news about: Epidemic Sound